Figures computed from official regulatory filings — .
| Insider | Type | Value · USD | Details | |
|---|---|---|---|---|
| KPCB XIV Associates, LLC | Other | $213.3M | SEC | |
| VAN VLASSELAER PETER |
| OtherD (derivative) |
| $9.3M |
| SEC |
| VAN VLASSELAER PETER | Other | $40.5M | SEC |
| Xu Stella | OtherD (derivative) | $180.5K | SEC |
| SEIDENBERG BETH C | OtherD (derivative) | $180.5K | SEC |
| Rizvi Naiyer | OtherD (derivative) | $828.4K | SEC |
| Xu Stella | Other | $20.2M | SEC |
| Rizvi Naiyer | OtherD (derivative) | $180.5K | SEC |
| VAN VLASSELAER PETER | OtherD (derivative) | $10.7M | SEC |
| GORDON CARL L | Other | $20.5M | SEC |
| VAN VLASSELAER PETER | OtherD (derivative) | $18.6M | SEC |
| CROSS HERB | OtherD (derivative) | $10.4M | SEC |
| Cui Xiangmin | Other | $60.7M | SEC |
| GORDON CARL L | Other | $185.5M | SEC |
| VAN VLASSELAER PETER | OtherD (derivative) | $9.3M | SEC |
| Legault Pierre | OtherD (derivative) | $180.5K | SEC |
| SEIDENBERG BETH C | Other | $213.3M | SEC |
| OrbiMed Capital GP IV LLC | Other | $185.5M | SEC |
| Cui Xiangmin | OtherD (derivative) | $180.5K | SEC |
| OrbiMed Capital GP IV LLC | Other | $20.5M | SEC |
| GORDON CARL L | OtherD (derivative) | $180.5K | SEC |
| Legault Pierre | OtherD (derivative) | $2.4M | SEC |
| Leveque Joseph | OtherD (derivative) | $12.4M | SEC |
| GORDON CARL L | AwardD (derivative) | — | SEC |
| SEIDENBERG BETH C | AwardD (derivative) | — | SEC |